A Simplified Positive-Sense-RNA Virus Construction Approach That Enhances Analysis Throughput by Siridechadilok, B et al.
A Simplified Positive-Sense-RNA Virus Construction Approach That
Enhances Analysis Throughput
Bunpote Siridechadilok,a Methee Gomutsukhavadee,a Thunyarat Sawaengpol,a Sutha Sangiambut,a Chunya Puttikhunt,a
Kwanrutai Chin-inmanu,b Prapat Suriyaphol,b Prida Malasit,a,c Gavin Screaton,d Juthathip Mongkolsapayac,d
National Center For Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency, Pathumthani, Thailanda; Bioinformatics
and Data Management for Research Unit, Office of Research and Development, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailandb; Dengue
Hemorrhagic Fever Unit, Office of Research and Development, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailandc; Molecular Immunology Unit,
Hammersmith Campus, Department of Medicine, Imperial College London, London, United Kingdomd
Here we present an approach that advances the throughput of a genetic analysis of a positive-sense RNA virus by simplifying
virus construction. It enabled comprehensive dissection of a complex, multigene phenotype through rapid derivation of a large
number of chimeric viruses and construction of a mutant library directly from a virus pool. The versatility of the approach de-
scribed here expands the applicability of diverse genetic approaches to study these viruses.
An important genetic tool to study animal, positive-senseRNA viruses is the infectious clone, a form of viral genome
cloned on a plasmid that can be propagated in Escherichia coli
and manipulated for reverse-genetics analysis. While the tool
has yielded important insights into viral infection and is critical
for generating vaccine candidates, the instability of certain viral
genome sequences in E. coli (especially in the cases of most
flaviviruses [1] and coronaviruses [2] and of some picornavi-
ruses [3], togaviruses [4], and pestiviruses [5]) has limited the
scale of genetic analyses for these viruses. The instability is still
not well understood. Consequently, each mutant construct
must be extensively sequenced to verify the absence of adven-
titious mutations, potentially resulting in months of efforts
to establish one such clone. Though there are many cloning
approaches to mitigate the instability (6–11), a large-scale ge-
netic analysis relying on cloning methods still requires signifi-
cant efforts to establish the mutant or chimeric viruses. In ad-
dition, the cloning methods are not adept at capturing the
diversity of a virus pool for manipulation and screening, hin-
dering the application of available genetic approaches to study
viruses.
Here, we describe a simple virus construction approach which
could bypass cloning and which eliminated its limitations in a
large-scale genetic analysis of dengue viruses (DENV). TheDENV
genome could be reconstructed frommultiple PCRproducts (am-
plified from cDNA) in a single DNA assembly reaction. Unlike the
conventional DNA ligation method, DNA assembly by Gibson
assembly (12), which was used in this technique, stitches DNA
through overlapping, homologous sequences at the ends of DNA
fragments, thus negating any need to introduce foreign sequences
to accommodate ligation and providing the flexibility of being
able to joinDNA at any locations on the viral genome. To produce
virus from DNA, viral PCR products, amplified from viral cDNA
using high-fidelity polymerase with proofreading activity, were
assembled onto an expression plasmid with a cytomegalovirus
(CMV) promoter that precisely initiated transcription on the vi-
rus genome sequence and a terminator, such as hepatitis D virus
(HDV) ribozyme, that accurately generated 3= end of the tran-
scribed viral RNA (13, 14) (Fig. 1A).
MATERIALS AND METHODS
Cells and virus. 293T cells weremaintained in Dulbecco’s modified Eagle
medium (DMEM) supplemented with 10% heat-inactivated fetal calf se-
rum, 1 mM glutamine, 1 mM sodium pyruvate, 20 mMHEPES, and high
glucose (4.5 g/liter). C6/36 cells were maintained at 28°C in L15 supple-
mented with 10% tryptose phosphate broth, 1 mM glutamine, and 10%
heat-inactivated fetal calf serum. Vero cells were maintained at 37°C with
5%CO2 and 80%humidity inMEM supplemented with 1mMglutamine
and 10% fetal-calf serum. DENV4-H241 and DENV2-16681 were cul-
tured in C6/36 cells that were maintained in L15 supplemented with 10%
tryptose phosphate broth, 1 mM glutamine, and 1.5% heat-inactivated
fetal calf serum after infection. All media used in this study were also
supplemented with penicillin/streptomycin.
DV4 strain v17 was generated by serial passaging of DENV4-H241 in
Vero cells for 17 passages. DV4 strain 4.1 was isolated in the form of an
infectious clone constructed from DENV4-H241 virus stock. The con-
struct of DENV4 strain 4.1 was cloned and propagated in E. coli XL10
Gold strain (Agilent) cultured at 22°C in LB medium.
Construction of the expression plasmid. A CMV promoter was ob-
tained by PCR amplification from pcDNA 3.1() Hygro (Invitrogen).
HDV ribozyme and SV40 PA (sequence based on the work by Var-
navski et al. [14]) was synthesized and cloned on a high-copy-number
vector with flanking NheI and BamHI sites (Invitrogen). The CMV
promoter, HDV ribozyme, and SV40PA were assembled onto a pUC19
backbone first with In-fusion HD (Clontech) and later by conven-
tional restriction ligation (NheI and BamHI sites). The plasmid con-
struct was verified by sequencing.
cDNA synthesis and PCR amplification. Viral RNA was extracted
from culture media with QIAamp viral RNA extraction kit according to
the manufacturer’s protocol (Qiagen). cDNA synthesis of the virus was
carried out with Superscript III first-strand synthesis kit (Invitrogen) ac-
cording to Chin-inmanu et al. (15). The primers for cDNA synthesis were
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10601-10621-rv-dv4 and 10639-10661-rv-dv2 for DENV4 and DENV2,
respectively. Primer sequences are shown in Table 1.
PCR products for assembly of viral constructs were carried out with
high-fidelity DNA polymerases (Phusion [NEB] and KAPA HiFi [KAPA
Bioscience]) according to the manufacturers’ protocols. All the PCR
products were cleaned up using a PCR cleanup kit from Invitrogen before
use in DNA assembly and sequencing.
PCR products of the expression vector (for assembly with viral PCR
products) were amplified with hCMV-rv and HDV-fw-dv4 (for DENV4)
or HDV-fw-dv2 (for DENV2).
PCR amplifications of cDNAs of DENV4-H241 (and DENV2-16681)
genomes were carried out by two pairs of primers: CMV-5= UTR-DV4
(DV2) andDV4-6671-6698-rv (or DV2-6685-6709-rv) for the first half of
the genome; DV4-6671-6698-fw (or DV2-6685-6709-fw) and 3= UTR-
DV4 (orDV2) for the secondhalf of the genome. PCRwas performedwith
Phusion polymerase (NEB).
Eleven PCR products were generated from v17 cDNA by 11 pairs of
primers: CMV-5= UTR-DV4 and C-dv4-start-rv (5= untranslated region
[UTR]), C-dv4-start-fw and prM-dv4-start-rv (C), prM-dv4-start-fw and
E-dv4-end-rv (prM-E), E-dv4-end-fw and NS1-dv4-end-rv (NS1), NS1-
dv4-end-fw andNS2A-dv4-end-rw (NS2A), NS2A-dv4-end-fw andNS3-
dv4-start-rv (NS2B), NS3-dv4-start-fw andNS3-dv4-end-rv (NS3), NS3-
dv4-end-fw and NS4A-2K-dv4-end-rv (NS4A), NS4A-2K-dv4-end-fw
and NS5-dv4-start-rv (NS4B), NS5-dv4-start-fw and NS5-dv4-end-rv
(NS5), and NS5-dv4-end-fw and 3= UTR-DV4 (3= UTR).
Virus construction and production. Cleaned-up PCR products of
both the expression vector and viral cDNA were assembled together in a
Gibson enzyme mix according to the one-step isothermal assembly pro-
tocol detailed by Gibson et al. (12). For this study, the overlaps between
fragments to be assembledwere in the range of 20 to 40 bp. The formula of
the enzymemix for overlap between 20 to 150 bp was used for the assem-
bly (12). PCR products of the expression vector (0.02 to 0.04 pmol) were
assembledwith 0.04 to 0.08 pmol of each PCRproduct of the viral genome
in the enzymemix tomake up 20l of the assembly reactionmixture. The
Gibson ligation reaction mixture (7 to 20 l; approximately 40 to 120 ng
of mixed PCR products) was diluted in Opti-MEM I medium and mixed
with Lipofectamine 2000 according to the protocol provided bymanufac-
turer (Invitrogen). 293T cells in either 35-mm dishes or 24-well plates
were washed twice with Opti-MEM before addition of the DNA-Lipo-
fectamine complex solution to the cells. Transfection was performed for 4
FIG 1 Construction of DENV by Gibson assembly. (A) Assembly schemes of DENV infectious DNA. CMV, CMV promoter; HDV, HDV ribozyme; SV40PA,
polyadenylation signal. (Left) Assembly scheme for DENV2-16681 and DENV4-H241; (right) assembly scheme for DENV4-v17. (B) The comparison between
the foci of the original virus stocks and the foci of viruses recovered throughGibson assembly. The number of DENVPCR products assembled (# PCR) is shown.
(C) PCRproducts for sequencing of virus recovered from transfected 293T cells were generated fromcDNAandnot contaminated assembledDNA., viral RNA
was treated with RNase A during cDNA synthesis. (D) Comparison between sequence heterogeneities of the original v17 strain, v17 recovered by our method,
and v17 cultured in C6/36 cells. The heterogeneous positions are highlighted in yellow.
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h at 37°C before the medium was changed to DMEM supplemented with
10% heat-inactivated fetal calf serum, 1 mM glutamine, 1 mM sodium
pyruvate, 20 mM HEPES, and high glucose (4.5 g/liter). The cultured
mediumwas harvested and replenished on the second and third days after
transfection. For mapping and library construction experiments (see Fig.
3 and 4), ISF-1 (Biochrom) was used instead of DMEM. Harvestedmedia
were clarified of debris and dead cells by centrifugation at 3,000 g and
4°C for 5 min. The clarified medium was stored at70°C for subsequent
infection, virus titration, and viral RNA extraction for sequencing.
Virus titration by focus-forming assay. Vero cells (90% conflu-
ence) in 96-well plate were used for titration. Infection was carried out at
37°C for 3 h before the cells were overlaid with MEM supplemented with
2% fetal bovine serum (FBS) and 1.5% carboxymethyl cellulose. Infected
cells were incubated at 37°C for 3 days before fixation with 3.7% formal-
dehyde in 1 phosphate-buffered saline (PBS) and permeabilized with
2% Triton X-100 in 1 PBS. Staining was performed with 4G2 as the
primary antibody, horseradish peroxidase (HRP)-conjugated anti-mouse
IgG as the secondary antibody, and DAB (3,3=-diaminobenzidine) as the
chromogenic substrate.
Focus quantitation.Dried, stained virus titer plates were scanned and
digitized with a KS ELISPOT reader (Carl Zeiss). Well images were ex-
tracted in Photoshop (Adobe). Foci in each well image were characterized
in ImageJ (16).Well imageswere converted to binary form to separate foci
and background. Then, the areas of foci in the binary image were quanti-
tated (the number of pixels) using the “Analyze Particles” function.
Sequencing of virus. DNA sequencing of virus was performed with
PCR products derived from viral cDNA. PCR amplification for sequenc-
ing was performed with either Phusion polymerase (NEB) or Accuprime
high-fidelity Taq polymerase (Invitrogen). To control for the contamina-
tion of assembled DNA from transfection reaction, another cDNA syn-
thesis reaction with RNase A (Fermentas) was also set up. PCR amplifica-
tion of the cDNA plus RNase A did not yield specific PCR products,
showing that PCR products were derived from RNA (Fig. 1C). The se-
quence chromatograms were analyzed and displayed using the 4Peaks
program (Mekentosj).
Growth curve comparison. At least three independent experiments
were performed for each virus tested for growth curve. The recovered
viruses from Gibson assembly using DENV4-H241, DENV2-16681 and
DENV4-v17 were compared against the original control viruses, and in
the case of DENV2-16681, we also compared growth with that of virus
produced from an infectious clone (a gift from N. Sittisombut). DENV2-
16681 from the infectious clone, which had been derived from the trans-
fection of capped in vitro transcribed viral RNA into C6/36 (17), was
expanded in C6/36 before use. To perform growth curve comparisons,
confluent Vero cells in 24-well plates were infected at a multiplicity of
infection (MOI) of 0.25 (DENV2-16681 and DENV4-v17) or 0.01
(DENV4-H241) in 500 l MEM supplemented with 2% heat-inactivated
fetal calf serum. Infection was carried out for 2 h at 37°C with 5% CO2.
After infection, the cells were washed three times with 1 ml plain MEM.
The infected cells were then supplemented with 1mlMEM supplemented
with 2%heat-inactivated fetal calf serum. Themedium from infected cells
was collected for virus titration at every 24 to 26 h.
Genetic mapping. Eleven PCR products derived from strain 4.1 were
generated by the set of primers used for strain v17. Another set of PCR
products that cover two genes from both strains were also constructed to
facilitate assembly using the same set of primers. Viruses in Fig. 3 were
constructed from different combinations of 11 genes from both strains.
To further map the mutations in E and prM, each gene was broken down
with two pairs of primers. For E, the pairs E-dv4-start-fw plus midE-dv4-
1587-1610-rv (E1527) and midE-dv4-1587-1610-fw plus E-dv4-end-rv
(E1690) were used. For prM, prM-dv4-start-fw plus M-dv4-start-rv
(prM550) and M-dv4-start-fw plus E-dv4-start-rv (M847) were used.
Virus library construction. To diversify the codon that encodes the
amino acid specified at position E1690, E genewas reconstituted from two
PCR products generated by two pairs of primers: E-dv4-start-fw plus
E1690-random-dv4-rv and post-E1690-fw plus E-dv4-end-rv. These two
PCR products were incorporated in the assembly reaction to construct
diversified E gene for the viruses.
RESULTS
Recovery of dengue viruses with Gibson assembly. Transfection
of 15l of the assembly reaction into 293T cells (seeded in 35-mm
dishes at250,000 cells/dish) using 10 l of Lipofectamine 2000
and 500 l Opti-MEM-I (Invitrogen) produced virus (up to 105
focus-forming units [FFU]/ml) in culture media within a few
days. Recovered virus had the same characteristic foci as the orig-
TABLE 1 Primers used in construction of viruses
Primer name Sequence (5= to 3=)
CMV-5= UTR-DV4 AGAGCTCGTTTAGTGAACCGAGTTGTTAGT
CTGTGTGGACCGACAAGGAC
CMV-5= UTR-DV2 AGAGCTCGTTTAGTGAACCGAGTTGTTAGT
CTACGTGGACCGACAAAGACAG
DV4-6671-6698-rv ATGATTGAGGCCGCTATCCACTG
DV4-6671-6698-fw TGGATAGCGGCCTCAATCATACTAGAG
DV2-6685-6709-rv CCAGTATTATTGAAGCTGCTATCCA
DV2-6685-6709-fw CTTCAATAATACTGGAGTTTTTTCTCATAG
3= UTR-DV4 AGAACCTGTTGGATCAACAACACCAATCCA
TCTCGCGGCGTTCTGTGCCTGGAATGAT
3= UTR-DV2 AGAACCTGTTGATTCAACAGCACCATTCCA
TTTTCTGGCGTTCTGTGCCTGGAATGAT
hCMV-rv CGGTTCACTAAACGAGCTCTGCTTATATAG
ACCTCCCACCG
HDV-fw-dv4 TTGTTGATCCAACAGGTTCTGGGTCGGCA
TGGCATCTCC
HDV-fw-dv2 CTGTTGAATCAACAGGTTCTGGGTCGGCA
TGGCATCTCC
10601-10621-rv-dv4 CGGCGCTCTGTGCCTGGATTG
10639-10661-rv-dv2 TGGCGTTCTGTGCCTGGAATGAT
C-dv4-start-rv CTAACCACCTTTTTTCGTTGGTTCAT
C-dv4-start-fw ATGAACCAACGAAAAAAGGTGGTTAG
prM-dv4-start-rv CGCCATCTCTTGTTGACAAGTG
prM-dv4-start-fw CACTTGTCAACAAGAGATGGCG
E-dv4-start-rv TCCCCACTCCCACGCATCG
E-dv4-start-fw CGATGCGTGGGAGTGGGGA
E-dv4-end-rv GTCTGCGTGAACTGTGAAACCC
E-dv4-end-fw GGGTTTCACAGTTCACGCAGAC
NS1-dv4-end-rv GGCCGATACCTGTGATTTGACC
NS1-dv4-end-fw GGTCAAATCACAGGTATCGGCC
NS2A-dv4-end-rv TCTCTTTGAAGCTCCTTTCATGAGAGTC
NS2A-dv4-end-fw GACTCTCATGAAAGGAGCTTCAAAGAGA
NS3-dv4-start-rv GACGTCCCACAGGGCTCCTGA
NS3-dv4-start-fw TCAGGAGCCCTGTGGGACGTC
NS3-dv4-end-rv CTTTCTTCCACTGGCAAACTCCTTG
NS3-dv4-end-fw CAAGGAGTTTGCCAGTGGAAGAAAG
NS4A-2K-dv4-end-rv GGCTGCTATGAGACCAATAATGGTG
NS4A-2K-dv4-end-fw CACCATTATTGGTCTCATAGCAGCC
NS5-dv4-start-rv GTCTCTCCTGTGGTCCCAGTTCC
NS5-dv4-start-fw GGAACTGGGACCACAGGAGAGAC
NS5-dv4-end-rv CAGAACTCCTTCACTCTCGAAAGG
NS5-dv4-end-fw CCTTTCGAGAGTGAAGGAGTTCTG
midE-dv4-1587-1610-rv CCAATGAACTTCTGATGTGTCTGC
midE-dv4-1587-1610-fw GCAGACACATCAGAAGTTCATTGG
M-dv4-start-rv CATTCCTGAATGTGGTGTTAGGGCTA
M-dv4-start-fw TAGCCCTAACACCACATTCAGGAATG
Post-E1690-fw GTGCTAGGATCTCAGGAAGGAGC
E1690-random-dv4-rv GCTCCTTCCTGAGATCCTAGCACNNNCAC
ATCCTGTCTCTTGGCATGAG
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inal virus stocks (Fig. 1B). The recovery depended on intactness of
assembled DNA, as determined by excluding a genome segment
or treatment with DNase before transfection inhibited virus pro-
duction (data not shown). The viruses could be produced from as
many as 11 viral PCR products (Fig. 1B, strain v17). DNA se-
quencing of the recovered DENV4-v17 showed sequence hetero-
geneities at two positions, as observed in the original DENV4-v17
stock used to derive its template cDNA, while further culture of
DENV4-v17 in C6/36 cells, a mosquito cell line usually used for
DENV isolation and recovery, lost the NS4B mutations (Fig. 1C).
The heterogeneities in focus size and sequence of the recovered
viruses demonstrated the ability of this technique to retain a pool
of virus mutants. In addition to similar focus characteristics, the
recovered viruses also possessed growth curves similar to those of
either the original viruses used as PCR templates or virus derived
from an infectious clone, in the case of DENV2-16681 (Fig. 2A to
C).
In addition to recovery of a heterogeneous viral pool, Gibson
assembly could be used for efficient construction of mutant vi-
ruses. To date, over 100 mutant DENVs (in addition to the ones
presented here) have been constructed by this approach. Sequence
verification by the Sanger method (10 viruses fully sequenced and
the rest sequenced on the mutant genes and the assembled sites)
confirmed that the desiredmutations were obtained in all cases. A
comparison between the foci of a set of mutant viruses generated
from Gibson assembly and from a sequence-verified infectious
clone also showed similar phenotypes (Fig. 2D).
Convenient shuffling of viral genome segments for charac-
terization of mutations. The ability to conveniently and accu-
rately construct a virus from a set of multiple PCR products or
DNA fragments, with each representing a viral gene or genetic
element (as shown for strain v17 in Fig. 1B), would greatly facili-
tate genetic mapping. It enables convenient derivation of numer-
ous chimeric viruses from shuffling a set of PCR products or DNA
fragments of genes/loci of two viruses. Instead of having to verify
the DNA sequence of each full-length chimeric clone, as required
by the infectious-clone approach, the shuffling requires sequenc-
ing of only two sets of viral DNA templates, greatly cutting down
sequence verification in a large-scale mapping effort. In addi-
tion, the ease of recombining different virus strains offered by
this scheme would provide a powerful basis that is not natural
for single-genome RNA viruses but is indispensable for for-
ward genetics of many organisms and viruses with segmented
genomes.
To demonstrate the utility of this technique in mapping, we
“crossed” two dengue strains with large (strain v17) and small
(strain 4.1) foci by shuffling PCR products of their genes or loci to
produce chimeric viruses. The viruses produced directly from
transfected 293T cells were directly used for phenotype character-
ization to minimize the effects from random PCR errors that
could be enriched or amplified during subsequent virus culture to
expand the virus stocks. We characterized the foci of progeny
viruses to determine which genetic differences between the two
(Table 2) conferred their phenotypes. Focus size is an indicator of
FIG 2 Growth comparison of DENV2-16681, v17, and H241 DENVs derived from Gibson assembly, conventional virus culture (original viruses), and the
infectious clone (17). All the experiments were performedwithVero cells. (A-C) show the growth curves ofDENV2-16681 (MOI 0.25), v17 (MOI 0.25), and
H241 (MOI  0.01), respectively. Error bar  standard error. (D) Focus comparison between the mutant viruses constructed from Gibson assembly of PCR
products (bottom row) and by conventional infectious-clone method (top row). The viruses used in focus comparison correspond to the viruses with the same
label in Fig. 3A (E and NS4B; left-hand panel), and 3D (E1690 and E1527NS4B).
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how well a virus replicates. A genetic variant that changes focus
size can affect the replication of the virus.
The mapping was done in three stages. First, we characterized
the chimeric viruses derived from single-gene swaps to identify
target genes (Fig. 3A and B). Replacement of either E or NS4B in
v17 with the sequences from 4.1 caused a dramatic reduction in
focus size (Fig. 3B). The reverse experiment, where single seg-
ments from v17 were moved into the 4.1 background, suggested a
role for Ewhich increased focus size but not to the level seen in v17
(Fig. 3A).
To characterize further elements contributing to the focus sizes
of v17 and 4.1, we went on tomake and characterize a panel of v17
gene combinations inserted into 4.1 that could retrieve the phe-
notype.We found that the combination of prM, E,NS4B, andNS5
of v17 could reconstitute the large v17 foci (Fig. 3C). Since there
are two nonsynonymous differences between 4.1 and v17 in the E
and prM sequences each (E at positions E1527 and E1690; prM at
positions prM550 and prM847) (Table 2), we tested which of
them could account for the effect of those two genes. We con-
structed additional 18 chimeric 4.1 viruses with single or com-
bined changes at these positions. The focus sizes of a subset of
these viruses (Fig. 3D, asterisks) suggested that the v17 mutations
at position prM550 and E1690 could replace the prMandE of v17,
respectively, in reconstituting v17 foci (Fig. 3D).
Constructionof a dengue virus library.WithPCRproducts as
the building blocks for viral infectious DNA, the approach can
exploit various PCR techniques (error-prone PCR, DNA shuf-
fling, and PCR with degenerate primers) to diversify virus se-
quences to produce mutant libraries. Screening and sorting of the
libraries provide powerful methods to study the genetic basis of
a phenotype. We created a virus library using a degenerate
primer to randomize an amino acid at position E1690 (Fig.
4A). The mapping in Fig. 3 showed that the amino acid at
E1690 has a strong influence on the focus size. Randomizing
the amino acid at this position will generate a DENV library
that can be used to study how the property of this critical amino
acid affects focus size.
A DENV library was created by combining PCR products of
prM, E (randomized at E1690), andNS4B from strain v17 and the
rest from strain 4.1. Sequencing of the recovered viruses showed
the scrambling of the sequence at the target position (Fig. 4B,
E1690). The sequence chromatograms of prM847 (Fig. 4B, M)
andNS4B7016 (Fig. 4B,NS4B) showed heterogeneity, as observed
with the original DENV4-v17 stock (Fig. 1D). The focus assay of
the DENV library indicated the presence of small-focus viruses
that were not present when the amino acid at E1690 was not ran-
domized in the same genetic background (Fig. 4C). Thus, by as-
sembling the scrambled PCR products with those derived from
heterogeneous viral cDNAs, this technique could directly diversify
an existing pool of virus mutants. This capability is essential in
directed-evolution experiments, where the mutant pool selected
from each round is directly diversified for the next round of selec-
tion.
DISCUSSION
The ease of assembling PCR products by Gibson assembly greatly
simplifies genetic engineering of viral genomes. Traditional DNA
ligation relies on complementary sticky ends generated by cutting
DNAwith restriction enzymes. The use of restriction enzymes has
limited DNA assembly from multiple PCR products, as adding
TABLE 2 Summary of sequence differences between strains v17
and 4.1a
a Nucleotide differences are highlighted in yellow.
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restriction sites must not interfere with the functions of the se-
quences at the joints. The restriction sites must also be unique to
specifically ligate DNA. Seamless DNA assembly techniques, such
as Gibson assembly (12), In-fusion (Agilent) (18, 19), SLIC (20),
and SLiCE (21), could solve this problem by generating sticky
ends on any linearDNA. Subsequent annealing of complementary
single-stranded DNA overhangs and ligation of annealed frag-
ments joins the DNA in a specific manner. Similar seamless as-
sembly, such as CPEC (22) and SHA (23), relies on the annealing
of cDNA strands at the ends to join DNA fragments during PCR
amplification. In principle, any of these seamless DNA assembly
techniques may be substituted for Gibson assembly in the virus
construction approach presented here. Very recently, CPEC was
applied to construct West Nile viruses in a similar bacterium-free
approach for virus construction (24). The virus construction by
CPEC could achieve similar recovery of the heterogeneity of a
West Nile virus stock (24). Together, these results show the appli-
cability of a seamless technique in virus recovery.
The ease of constructing viruses frommultipleDNA fragments
provided by this method can facilitate genetic mapping and
screening of mutations (Fig. 3). The capability of Gibson assem-
bly, as demonstrated in its application to the construction of mi-
tochondrial genomes from oligonucleotides (25), would accom-
modate even finer fragmentation of viral genomes than ours
(Fig. 1A) and make the approach applicable to RNA viruses with
larger genomes, such as coronaviruses. While the data presented
here show high accuracy of reconstructing viruses by this method,
the possibility of unintended mutations caused by random PCR
errors cannot be ruled outwhen viruses are constructed fromPCR
products. Confirming the identified mutations with additional
methods and assays, such as full-genome sequencing of the de-
rived viruses, will prevent such errors.
The virus construction approach described here addresses the
throughput limitations of infectious clones. It shortens the con-
struction time from months to days. It can recover the genetic
diversity in the virus stock (Fig. 1B andD). It significantly reduces
the amount of sequence verification required in a large-scale ge-
netic analysis through the ease of recombining viruses (Fig. 3). It
FIG 3 Crossing small-focus (strain 4.1) and large-focus (strain v17) viruses to map the mutations that confer large foci. (A) Foci of the chimeric viruses with a
single segment or gene (x axis) of v17 replaced with the one from the other strain in the 4.1 background. (B) Reverse of the single-gene swaps (A). The v17
gene/segment was replaced with the corresponding one from 4.1. The focus sizes were measured as the average of the number of pixels occupied by the foci (y
axis). Error bars show standard deviations. Well images from focus assays of the viruses are shown above the bars. (C) Foci of the chimeric viruses with the
combinations of genes in strain 4.1 replaced with the ones from v17. (D) The influences of v17 mutations at positions prM550, prM847, E1527, and E1690 in
reconstituting v17 focus size in the 4.1 background. The asterisks indicate the viruses that implicate the roles of the v17 mutations at prM550 and E1690 in
retrieving v17 foci.
Siridechadilok et al.
12672 jvi.asm.org Journal of Virology
enables direct genetic manipulation of a virus mutant pool (Fig.
4). By eliminating these limitations, this approach supports large-
scale forward genetics (Fig. 3) and expands our current ability to
mutate viruses for reverse genetics and directed-evolution exper-
iments (Fig. 4). Its capability is based on direct exploitation of
PCR products amplified from viral cDNA as building blocks to
construct infectious viral DNA in a single, highly efficient reaction
of Gibson assembly. The throughput capability gained will sup-
port functional characterization of virus variants, which are being
discovered at a breakneck pace by next-generation sequencing.
Since it relies on a DNA-based expression format applicable to
many positive-sense RNA viruses, its utility will be relevant to
these viruses (13, 26, 27). The technique should accelerate vaccine
and antiviral-drug development to fight against many pathogenic
positive-sense RNA viruses.
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